her 2 negative breast cancer
Showing 1 - 1 of 1
Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer Trial in Germany (Ribociclib and aromatase
Active, not recruiting
- Breast Cancer
- +2 more
- Ribociclib and aromatase inhibitor or fulvestrant
- Capecitabine + bevacizumab OR Paclitaxel +/- bevacizumab
-
Ravensburg, Baden-Wuerttemberg, Germany
- +26 more
Dec 1, 2021